Carbon (DLC)-coating which serves as an effective barrier against leakage of heavy metal ions (i.e. Cr, Ni, Mo) from surgical stainless steel 316L. Furthermore PlasmaChem has developed new generations of cardio-surgical implants - implants with controlled drug elution and biosoluble (biodegradable) temporary implants.

In the area of medical devices PlasmaChem GmbH has developed also leading-edge contact lenses of long wear (> 90 days/nights permanent usage). In 2004 a new company was founded in cooperation with Bayer AG, Germany (Leverkusen) for manufacturing and promotion of these products. This company — Lenswista AG — is now located in Berlin/Adlershof too.

Plasmachem performs chemical and low temperature plasma modification of nanopowders with the purpose of functionalization of nano-particle's surface assisted by new plasma-chemical methods developed by PlasmaChem for ultra-dispersed materials. This approach leads to a new family of industrial nano-products with improved and tailor-made properties.

PlasmaChem GmbH developed a novel and unique surface analysis method — NanoLuminography. The R&D phase has been completed, several patent applications were filed and granted already at national phase. A first commercial prototype is recently in progress.